Alzamend Neuro (ALZN) Operating Expenses (2020 - 2026)
Alzamend Neuro (ALZN) reported Operating Expenses of $3.03 million for fiscal Q1 2027 (quarter ended Jul 31, 2026), up 12.0% from $2.7 million a year earlier and up 5.4% from the prior quarter.
Powered by 
Analysis
Alzamend Neuro (ALZN) Operating Expenses (2020 - 2026) Analysis & Trends
Over the twelve months ended Jul 31, 2026, Alzamend Neuro's Operating Expenses came in at $9.09 million, up 45.8% year-over-year; for FY2026 (ended Apr 30, 2026), it was $8.77 million, up 95.0% from FY2025.
- Operating Expenses has a five-year compound annual growth rate of 12.1% (FY2021 to FY2026).
- By fiscal year, Operating Expenses came in at $4.5 million in FY2025 (-54.7%), $9.94 million in FY2024 (-33.2%), $14.87 million in FY2023 (+20.7%) and $12.32 million in FY2022 (+148.8%).
- The fiscal Q1 2027 figure ranks as the highest quarterly Operating Expenses since fiscal Q1 2024.
- Year over year, Operating Expenses has now increased in each of the last three quarters, with growth averaging 43.7% over the last eight quarters.
- The high point for year-over-year Operating Expenses in five years was fiscal Q4 2022 (growth of 217.4%); the low point was fiscal Q4 2024 (a decline of 74.3%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $2.87 million (Q4 2026), $2.2 million (Q3 2026) and $998,109 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -9.70 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 6.54 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 18.20 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 6.68 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 2.09 Bn |
| 10 | Alzamend Neuro | 8.78 Mn | 8.78 Mn | - | 3.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 3.03 Mn |
| Apr 30, 2026 | 2.87 Mn |
| Jan 31, 2026 | 2.20 Mn |
| Oct 31, 2025 | 998,109.00 |
| Jul 31, 2025 | 2.70 Mn |
| Apr 30, 2025 | 1.14 Mn |
| Jan 31, 2025 | 1.04 Mn |
| Oct 31, 2024 | 1.36 Mn |
| Jul 31, 2024 | 962,405.00 |
| Apr 30, 2024 | 850,064.00 |
| Jan 31, 2024 | 2.66 Mn |
| Oct 31, 2023 | 2.90 Mn |
| Jul 31, 2023 | 3.53 Mn |
| Apr 30, 2023 | 3.31 Mn |
| Jan 31, 2023 | 5.42 Mn |
| Oct 31, 2022 | 3.11 Mn |
| Jul 31, 2022 | 3.04 Mn |
| Apr 30, 2022 | 3.87 Mn |
| Jan 31, 2022 | 2.56 Mn |
| Oct 31, 2021 | 3.58 Mn |
API Access
Alzamend Neuro Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();